Cipla Files Fresh Bid To Revoke Bayer's Xarelto Patent
An Indian pharmaceutical company has asked a London court to invalidate a Bayer Global AG patent that protects the blockbuster blood-thinner Xarelto, marking the latest attempt to nix the patent protecting...To view the full article, register now.
Already a subscriber? Click here to view full article